1. Which of the following is a rapid-acting insulin product?
A. Insulin detemir (Levemir)
B. Insulin aspart (Novolog)
C. Insulin glargine (Basaglar, Lantus, Toujeo)
D. Regular insulin
2. Basal insulin is responsible for which of the following actions?
A. Suppressing glucose production by the liver
B. Increasing glucose concentrations after meals
C. Reducing production of fatty acids
D. Stimulating ketone production
3. Which of the following is TRUE when initiating a basal-bolus insulin regimen in patients with type 2 diabetes mellitus (T2DM)?
A. Patients should monitor their blood glucose levels frequently
B. Insulin administration should begin with 4-times-daily dosing
C. Patients with T2DM should not use the basal-bolus method of insulin therapy
D. Therapy should be initiated with 10 units of regular insulin at bedtime
4. JP has type 2 diabetes mellitus (T2DM). Her provider has suggested that she initiate insulin therapy and she brings a prescription for a long-acting basal insulin to your pharmacy. She is reluctant to use insulin because she thinks insulin is only for patients who are nearing the end stages of the disease. How can you assure JP this is not the case?
A. Tell her that her diabetes has progressed to type 1 and, therefore, requires insulin therapy
B. Inform her that insulin is the most cost effective way to treat diabetes
C. Tell her that replacing insulin is an effective treatment for T2DM and it can be used early in the disease process for some patients
D. Tell her that a poor diet likely that caused her diabetes to get out of control and offer her a consultation with a dietician
5. Which one of the following is not an open-ended question that may be used to assess a patient's comfort level with insulin therapy?
A. Are you at the pharmacy today to pick up your prescription?
B. How have you been feeling since you started your insulin?
C. How are you tracking your blood sugars?
D. What difficulties do you have with your injections?
6. When educating a patient with type 2 diabetes about administering insulin, all of the following are appropriate recommendations, EXCEPT:
A. Inspect insulin vials for contamination
B. Inject insulin at a 90-degree angle
C. Withdraw needle quickly and apply light pressure to the injection site
D. Inject the insulin within 1 inch of the navel
7. RK has diabetes and is using insulin. He loses consciousness from a hypoglycemic event. Which of the following is a possible treatment option for RK?
A. Pour fruit juice directly down his throat
B. Inject an extra dose of insulin
C. Crumble cookies into his mouth
D. Administer glucagon
8. Which of the following is a common adverse event and a patient-level barrier associated with insulin use?
A. Mild hyperglycemia
B. Lipodystrophy
C. Painful injections
D. Weight loss
9. Consider the onset of action of insulin glulisine (Apidra). When is the most appropriate time to administer this insulin?
A. 0 to 5 minutes before a meal
B. 10 to 15 minutes after awakening in the morning, without regard to food intake
C. 30 to 60 minutes before a meal
D. 30 to 60 minutes after a meal
10. A patient is using a basal insulin product and asks if he needs to eat something each time he injects it. A correct counseling tip conveyed by the pharmacist might be:
A. Eat immediately after injecting any type of insulin, since the insulin will cause blood sugar levels to fall quickly
B. Drink a glass of milk after injecting insulin, since this will improve the absorption of insulin
C. You do not need to eat food after injecting basal insulin, since it acts as a low-dose background insulin throughout the day
D. You should eat a meal approximately 1 hour before you inject any type of insulin, because eating after you inject the insult may cause nausea
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. To what extent did the program meet objective #6?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
24. Will the information presented cause you to change your practice?
A. Yes
B. No
25. Are you committed to making these changes?
A. Yes
B. No
26. As a result of this activity, did you learn something new?
A. Yes
B. No
27. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
28. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
E. >20